Related Experiment Video
Updated: Feb 16, 2026

A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model
Published on: September 11, 2020
Role of microRNA in the detection, progression, and intervention of acute kidney injury
1Department of Nephrology, 66281 School of Medicine, Ruijin Hospital, Shanghai Jiao Tong University , Shanghai 200025, PR China.
Abstract:
Acute kidney injury, characterized by sharply decreased renal function, is a common and important complication in hospitalized patients. The pathological mechanism of acute kidney injury is mainly related to immune activation and inflammation. Given the high morbidity and mortality rates of hospitalized patients with acute kidney injury, the identification of biomarkers useful for assessing risk, making an early diagnosis, evaluating the prognosis, and classifying the injury severity is urgently needed. Furthermore, investigation into the development of acute kidney injury and potential therapeutic targets is required. While microRNA was first discovered in Caenorhabditis elegans, Gary Ruvkun's laboratory identified the first microRNA target gene. Together, these two important findings confirmed the existence of a novel post-transcriptional gene regulatory mechanism. Considering that serum creatinine tests often fail in the early detection of AKI, testing for microRNAs as early diagnostic biomarkers has shown great potential. Numerous studies have identified microRNAs that can serve as biomarkers for the detection of acute kidney injury. In addition, as microRNAs can control the expression of multiple proteins through hundreds or thousands of targets influencing multiple signaling pathways, the number of studies on the functions of microRNAs in AKI progression is increasing. Here, we mainly focus on research into microRNAs as biomarkers and explorations of their functions in acute kidney injury. Impact statement Firstly, we have discussed the potential advantages and limitations of miRNA as biomarkers. Secondly, we have summarized the role of miRNA in the progress of AKI. Finally, we have made a vision of miRNA's potential and advantages as therapeutic target intervention AKI.
Insights
MicroRNAs show promise as early diagnostic biomarkers for acute kidney injury (AKI), outperforming traditional tests. Research is exploring their role in AKI progression and potential as therapeutic targets.
Area of Science:
- Biomarkers and Molecular Diagnostics
- Renal Physiology and Pathology
- Gene Regulation and Therapeutics
Background:
- Acute kidney injury (AKI) is a critical complication in hospitalized patients, marked by rapid renal function decline and often linked to immune activation and inflammation.
- Current diagnostic methods like serum creatinine tests have limitations in early AKI detection, necessitating novel biomarkers.
- MicroRNAs (miRNAs) represent a class of small non-coding RNAs involved in post-transcriptional gene regulation.
Purpose of the Study:
- To review the potential of microRNAs as early diagnostic biomarkers for acute kidney injury.
- To summarize the current understanding of microRNA functions in the progression of acute kidney injury.
- To explore the advantages and limitations of microRNAs as biomarkers and potential therapeutic targets for AKI.
Main Methods:
- Literature review focusing on studies investigating microRNAs in the context of acute kidney injury.
- Analysis of research on microRNA identification, function, and therapeutic potential in AKI.
- Discussion of the advantages and limitations of microRNAs as diagnostic biomarkers and therapeutic targets.
Main Results:
- MicroRNAs have demonstrated significant potential as early diagnostic biomarkers for acute kidney injury, surpassing the sensitivity of conventional markers.
- Numerous microRNAs have been identified as potential biomarkers for AKI detection.
- MicroRNAs play a crucial role in regulating multiple signaling pathways involved in AKI progression.
Conclusions:
- MicroRNAs offer a promising avenue for early diagnosis and risk assessment of acute kidney injury.
- Further research into microRNA functions is essential for understanding AKI pathogenesis and developing targeted therapies.
- MicroRNAs hold potential as both diagnostic biomarkers and therapeutic targets for intervening in acute kidney injury.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations
Chronic Kidney Disease I: Introduction

